RTI Biologics launches new biologic implant for orthopedic and spine surgeries

RTI Biologics launches new biologic implant for orthopedic and spine surgeries (Equities)
RTI Biologics Inc., or RTI, a processor of orthopedic, dental, surgical specialties and other biologic implants, has launched a new biologic implant for use in sports medicine, orthopedic and spine surgeries.
According to the company, BioReady DBM Putty is an extension of RTI Biologics' DBM portfolio which includes BioSet DBM Paste and BioAdapt Foam. It is a demineralized bone matrix (DBM) implant that provides convenience, robust handling, verified osteoinductive potential and sterility.
BioReady DBM Put...